Neumora Therapeutics, Inc.
NMRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001885522
In the last 90 days, Neumora Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 113 institutions reported holding it in 13F filings for Q2 2026, worth $129.2M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Neumora Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- 0 vs. Q1 2026
- Shares held
- 76.0M
- +5.60M (+8.0%) vs. Q1 2026
- Total value
- $129.2M
- −$8.03M (−5.9%) vs. Q1 2026
- New holders
- 28
- 37 more added
- Sold out
- 28
- 23 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $129.2M |
| Q1 2026 | 114 | $137.2M |
| Q4 2025 | 102 | $112.7M |
| Q3 2025 | 93 | $92.2M |
| Q2 2025 | 98 | $41.1M |
| Q1 2025 | 116 | $65.2M |
| Q4 2024 | 135 | $851.6M |
| Q3 2024 | 104 | $907.0M |
| Q2 2024 | 93 | $627.4M |
| Q1 2024 | 88 | $725.4M |
| Q4 2023 | 60 | $744.8M |
| Q3 2023 | 38 | $512.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Neumora Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boxer Capital Management, LLC | 2,000,000 | $3.40M | 0.26% | +2,000,000 | New |
| Lunate Capital Ltd | 2,124,143 | $3.61M | 1.84% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,139,882 | $3.64M | 0.07% | +2,139,882 | New |
| Two Sigma Investments, LP | 2,244,829 | $3.82M | 0.00% | +208,137+10.2% | Added |
| ICONIQ Capital, LLC | 2,559,090 | $4.35M | 0.13% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 2,607,289 | $4.43M | 0.00% | +1,520,424+139.9% | Added |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 3,309,123 | $5.63M | 0.06% | 00.0% | Unchanged |
| FMR LLC | 3,498,869 | $5.95M | 0.00% | +2110.0% | Added |
| MIC Capital Management UK LLP | 4,460,700 | $7.58M | 1.92% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 4,669,585 | $7.94M | 0.00% | +777,692+20.0% | Added |
| Softbank Group Corp | 6,090,301 | $10.4M | 0.06% | 00.0% | Unchanged |
| BlackRock, Inc. | 7,791,869 | $13.2M | 0.00% | +5,737,553+279.3% | Added |
| Siren, L.L.C. | 8,497,822 | $14.4M | 0.29% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −5,104,097−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −818,156−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −602,403−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −511,084−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −439,878−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −198,851−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −191,677−100.0% | Sold out |
| SkyOak Wealth, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −110,875−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −97,075−100.0% | Sold out |
| Voleon Capital Management LP | 0 | $0 | 0.00% | −93,863−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −57,642−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −50,900−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −39,810−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −33,300−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −33,044−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −32,762−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,489−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −23,755−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −17,178−100.0% | Sold out |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −14,957−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −298−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −264−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −167−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |